Status:
RECRUITING
Reminder Emails to Improve Pneumococcal Vaccine Completion at 12 Months of Age
Lead Sponsor:
Ottawa Hospital Research Institute
Conditions:
Pneumococcal Vaccines
Immunization Coverage
Eligibility:
All Genders
10-11 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to assess the effectiveness of enhanced email reminders in improving vaccine coverage at the 12-month visit in CANImmunize app users. The main questions it aims to a...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- To be included in the study, CANImmunize account holders must have:
- Enabled the reception to receive emails from CANImmunize, and
- Record(s) for an infant aged between 10- and 11-months, who have already received the earlier doses of the pneumococcal vaccine in accordance with their provincial/territorial routine immunization schedule.
- Exclusion Criteria
- The account holder (parent, or guardian of the child) has an inactive or undelivered email address, or
- No record(s) for an infant aged 10- and 11-months, or
- The record for the 10- or 11-month-old indicates that he/she has not received the prior pneumococcal vaccine doses.
Exclusion
Key Trial Info
Start Date :
November 7 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT06000397
Start Date
November 7 2023
End Date
June 1 2024
Last Update
April 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CANImmunize
Ottawa, Canada